Federal Register / Vol. 74, No. 172 / Tuesday, September 8, 2009 / Notices 46229 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: August 21, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–21540 Filed 9–4–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application; Correction 

By Notice dated June 24, 2009, and 

published in the Federal Register on 

July 9, 2009, (74 FR 32954), the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, provided notice of 

application by Rhodes Technologies, 

498 Washington Street, Coventry, Rhode 

Island 02816, to be registered as an 

importer of basic classes of controlled 

substances listed in schedule II. The 

Notice of Application should be 

corrected by adding the following 

information: ‘‘The company plans to 

import the listed controlled substances 

to manufacture bulk active 

pharmaceutical ingredients.’’ 

Dated: August 21, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–21539 Filed 9–4–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated April 17, 2009, and 

published in the Federal Register on 

April 29, 2009 (74 FR 19595), Almac 

Clinical Services, Inc., (ASCI), 2661 

Audubon Road, Audubon, Pennsylvania 

19403, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the basic classes of controlled 

substances listed in schedule II: 

Drug Schedule 

Oxycodone (9143) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to import small 

quantities of the listed controlled 

substances in dosage form to conduct 

clinical trials. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Almac Clinical Services Inc. to import 

the basic classes of controlled 

substances is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971, at this time. DEA has 

investigated Almac Clinical Services 

Inc. to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with State 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: August 21, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–21538 Filed 9–4–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated April 17, 2009, and 

published in the Federal Register on 

April 29, 2009 (74 FR 19594), Meridian 

Medical Technologies, 2555 Hermelin 

Drive, St. Louis, Missouri 63144, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Morphine (9300), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import 

products for research experimentation 

or clinical use and analytical testing. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Meridian Medical Technologies to 

import the basic class of controlled 

substance is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971, at this time. DEA has 

investigated Meridian Medical 

Technologies to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: August 21, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–21537 Filed 9–4–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated April 17, 2009 and 

published in the Federal Register on 

April 29, 2009, (74 FR 19594), Penick 

Corporation, 33 Industrial Park Road, 

Pennsville, New Jersey 08070, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Coca Leaves (9040) ..................... II 

Opium, raw (9600) ....................... II 

Poppy Straw (9650) ..................... II 

Concentrate of Poppy Straw 

(9670).

II 

The company plans to import the 

listed controlled substances to 


jlentini on DSKJ8SOYB1PROD with NOTICES
46230 Federal Register / Vol. 74, No. 172 / Tuesday, September 8, 2009 / Notices 

manufacture bulk controlled substance 

intermediates for sale to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and § 952(a) 

and determined that the registration of 

Penick Corporation to import the basic 

classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971, at 

this time. DEA has investigated Penick 

Corporation to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: August 21, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–21536 Filed 9–4–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated June 3, 2009, and 

published in the Federal Register on 

June 9, 2009, (74 FR 27347), Research 

Triangle Institute, Kenneth H. Davis Jr., 

Hermann Building, East Institute Drive, 

P.O. Box 12194, Research Triangle, 

North Carolina 27709, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

1-(1-Phenylcyclohexyl)pyrrolidine 

(7458).

I 

1-[1-(2- 

Thienyl)cyclohexy]piperidine 

(7470).

I 

1-[1-(2- 

Thienyl)cyclohexyl]pyrrolidine 

(7473).

I 

1-Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

Drug Schedule 

1-(2-Phenylethyl)-4-phenyl-4- 

acetoxypiperidine (9663).

I 

2,5-Dimethoxy-4-(n)- 

propylthiophenethylamine 

(7348).

I 

2,5-Dimethoxy-4- 

ethylamphetamine (7399).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4,5-Trimethoxyamphetamine 

(7390).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

3,4- 

Methylenedioxymethamphetamine (7405).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3-Methylfentanyl (9813) ................ I 

3-Methylthiofentanyl (9833) .......... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

4-Methylaminorex (cis isomer) 

(1590).

I 

4-Methoxyamphetamine (7411) ... I 

5-Methoxy-3,4- 

methylenedioxyamphetamine 

(7401).

I 

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

Acetorphine (9319) ....................... I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Acetyldihydrocodeine (9051) ........ I 

Acetylmethadol (9601) ................. I 

Allylprodine (9602) ....................... I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alpha-ethyltryptamine (7249) ....... I 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Alpha-methylfentanyl (9814) ........ I 

Alpha-methylthiofentanyl (9832) ... I 

Alpha-methyltryptamine (7432) .... I 

Aminorex (1585) ........................... I 

Benzethidine (9606) ..................... I 

Benzylmorphine (9052) ................ I 

Betacetylmethadol (9607) ............ I 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Beta-hydroxyfentanyl (9830) ........ I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Bufotenine (7433) ......................... I 

Cathinone (1235) .......................... I 

Clonitazene (9612) ....................... I 

Codeine methylbromide (9070) .... I 

Codeine-N-Oxide (9053) .............. I 

Cyprenorphine (9054) .................. I 

Desomorphine (9055) ................... I 

Dextromoramide (9613) ............... I 

Diampromide (9615) ..................... I 

Diethylthiambutene (9616) ........... I 

Diethyltryptamine (7434) .............. I 

Difenoxin (9168) ........................... I 

Dihydromorphine (9145) ............... I 

Dimenoxadol (9617) ..................... I 

Dimepheptanol (9618) .................. I 

Drug Schedule 

Dimethylthiambutene (9619) ........ I 

Dimethyltryptamine (7435) ........... I 

Dioxaphetyl butyrate (9621) ......... I 

Dipipanone (9622) ........................ I 

Drotebanol (9335) ........................ I 

Ethylmethylthiambutene (9623) .... I 

Etonitazene (9624) ....................... I 

Etorphine except HCl (9056) ........ I 

Etoxeridine (9625) ........................ I 

Fenethylline (1503) ....................... I 

Furethidine (9626) ........................ I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Heroin (9200) ............................... I 

Hydromorphinol (9301) ................. I 

Hydroxypethidine (9627) .............. I 

Ibogaine (7260) ............................ I 

Ketobemidone (9628) ................... I 

Levomoramide (9629) .................. I 

Levophenacylmorphan (9631) ...... I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Mecloqualone (2572) .................... I 

Mescaline (7381) .......................... I 

Methaqualone (2565) ................... I 

Methcathinone (1237) .................. I 

Methyldesorphine (9302) .............. I 

Methyldihydromorphine (9304) ..... I 

Morpheridine (9632) ..................... I 

Morphine methylbromide (9305) .. I 

Morphine methylsulfonate (9306) I 

Morphine-N-Oxide (9307) ............. I 

Myrophine (9308) ......................... I 

N,N-Dimethylamphetamine (1480) I 

N-[1-(2-thienyl)methyl-4-piperidyl]- 

N-phenylpropanamide (9834).

I 

N-[1-benzyl-4-piperidyl]-Nphenylpropanamide (9818).I 

N-Benzylpiperazine (7493) ........... I 

N-Ethyl-3-piperidyl benzilate 

(7482).

I 

N-Ethylamphetamine (1475) ........ I 

N-Ethyl-l-phenylcyclohexylamine 

(7455).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

Nicocodeine (9309) ...................... I 

Nicomorphine (9312) .................... I 

N-Methyl-3-piperidyl benzilate 

(7484).

I 

Noracymethadol (9633) ................ I 

Norlevorphanol (9634) .................. I 

Normethadone (9635) .................. I 

Normorphine (9313) ..................... I 

Norpipanone (9636) ..................... I 

Para-Fluorofentanyl (9812) .......... I 

Parahexyl (7374) .......................... I 

Peyote (7415) ............................... I 

Phenadoxone (9637) .................... I 

Phenampromide (9638) ................ I 

Phenomorphan (9647) ................. I 

Phenoperidine (9641) ................... I 

Pholcodine (9314) ........................ I 

Piritramide (9642) ......................... I 

Proheptazine (9643) ..................... I 

Properidine (9644) ........................ I 

Propiram (9649) ........................... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

Racemoramide (9645) .................. I 

Tetrahydrocannabinols (7370) ..... I 

Thebacon (9315) .......................... I 

Thiofentanyl (9835) ...................... I 


jlentini on DSKJ8SOYB1PROD with NOTICES